SICPA &SICPATRACE - Presentation to the Ministry of Health of the Slovak Republic
Meeting place: Ministry of Health, Limbová 2, 83752
Date: 18 July, 2016
Participants:
Ministry of Health:
- Matej Petrovič, Acting Director General of the Department of Pharmacy and Drug Policy
- Rastislav Pullmann, Director of OKCLP
- Liliana Hrusiková, EU Affairs and International Cooperation Coordinator
SICPA, HMG Legal:
- Viktor Žemlička, Executive Vice President Business Development SICPA
- David Fradkoff, Government Solutions Manager SICPA
- Ondrej Vanovič, legal advisor HMG Legal
Background: Mr Žemlicka introduced the company and their product. The company was founded in 1927 in Switzerland and has branches in 27 countries. They provide unique solutions in the field of security ink, provide security features for banknotes, documents, coins, fast-moving goods for various governments, farm companies and organisations. It is a safe system for tracking the position and movement of products. The company has financial capacity for state contracts, where they are able to finance the introduction of the element into the production, then one of the financing options for the solution is accounting for the With the process of implementation, the company can start about 3-4 months from the respective agreements.
Mr Žemlicka mentioned creating room for further discussion due to the ratification of the Slovak Republic's 2012 Protocol to Eliminate Illicit Trade in Tobacco Products to the World Health Organisation Framework Convention on Tobacco Control. As President of the country in the Council of the EU, the Slovak Republic intends to act on the Member States in the area of ratification of the Protocol. After ratification of the key protocol, the government of the Slovak Republic will certainly have to start further dialogues on technical implementation. Articles 29,30 and 31 of the EC Tobacco Products Directive (Directive2014/40/EU) require the creation of a Track&Trace system.
The objective of Directive 2011/62/EU ('FMD') on falsified medicinal products is to prevent falsified medicinal products entering the legal supply chain and to patients. Mandatory safety features will need to be used on each pack of medicine. The implementation deadline for most Member States, including Slovakia, is until 9.2.2019. It is necessary to establish a national system and then switch to a European database. SICPA would finance a national system. SR with FMD introduction as a country is late, therefore Mr Zemlicka proposes MZ SR to play an active role in this process.
Tasks of the LA
inform State Secretary Andrea Kálava of the presentation.
contact SICPU in case of interest, when experts can meet and prepare a more detailed and technical view.